Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

ASRA Coags icon
ASRA Coags1.2 (578)

American Society of Regional Anesthesia and Pain Medicine

App Store

Report updated May 22, 2026

ASRA Coags is a struggling medical app that is available. With a 1.2/5 rating from 578 reviews, it struggles with user retention. Users particularly appreciate clinical utility of the perioperative anticoagulant scheduling tool remains highly valued by medical professionals, though forced subscription model revokes lifetime access previously purchased by long-term medical professional users remains a common concern.

What is ASRA Coags?

ASRA Coags is a medical reference app for anesthesiologists and pain specialists, providing searchable anticoagulation guidelines and procedure-based drug recommendations on iOS and Android.

Medical professionals hire this app to reduce clinical decision-making time during high-pressure procedures, using society-sanctioned data to ensure patient safety.

Current Momentum

v6.1 · 4mo ago

Steady
  • Implemented universal code base.
  • Integrated 2025 regional anesthesia guidelines.
  • Updated UI design.

Active Nemesis

Vargo Anesthesia Mega App

Vargo Anesthesia Mega App

By Vargo Anesthesia

Other Rivals

Anesthesia Central
UpToDate
MDCalc Medical Calculator
Calculate by QxMD
Doximity
Pedi STAT

7-Day Rank Pulse 🇺🇸

Medical

No ranking data

MedicalGrossing

Rating Pulse 🇺🇸

Recent User Mood

What makes this app unique?

What Does It Look Like?

What Are The Key Features?

Anticoagulation Guideline ReferenceDifferentiator

Searchable database of drug-specific recommendations for regional anesthesia and interventional pain procedures

Procedure-Based SearchStandard

Drug recommendations filtered by block type or procedure risk level

Full Guideline AccessDifferentiator

In-app access to the full 2025 regional and 2018 interventional pain guideline documents

How much does it cost?

Subscription
  • Free for ASRA Pain Medicine members
  • $6.99/annually for non-members

Subscription model anchored at $6.99/year, utilizing the app as a membership retention tool for the professional society.

Who Built It?

American Society of Regional Anesthesia and Pain Medicine app icon 1
American Society of Regional Anesthesia and Pain Medicine app icon 2
American Society of Regional Anesthesia and Pain Medicine app icon 3
American Society of Regional Anesthesia and Pain Medicine app icon 4

Providing medical professionals with evidence-based clinical guidelines and procedural checklists for regional anesthesia and pain management.

Portfolio

3

Apps

Free 2
Business50%
Medical50%

What other apps does American Society of Regional Anesthesia and Pain Medicine make?

Explore the full American Society of Regional Anesthesia and Pain Medicine report

Portfolio breakdown, audience, momentum, and every app published by American Society of Regional Anesthesia and Pain Medicine.

Go deeper

What do users think recently?

High confidence · 49 reviews analyzed

How did the latest release land?

Overall
1.2/ 5
(578)
Current version
1.3/ 5
+0.0 vs overall
(362)
Main signal post-update: clinical utility of the perioperative anticoagulant scheduling tool remains highly valued by medical professionals.

What is the recent mood?

Upset

Recent user voice shows a upset sentiment. Users appreciate clinical utility of the perioperative anticoagulant scheduling tool remains highly valued by medical professionals, but report forced subscription model revokes lifetime access previously purchased by long-term medical professional users and lack of grandfathering for legacy users creates significant friction and loss of trust in the brand.

Limited review volume (49 reviews). Sentiment analysis will deepen as more data lands.

View the full user-sentiment analysis

Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.

Go deeper

What is the competitive landscape for ASRA Coags?

How's The Medical Market?

How does it evolve in the Medical market?

ASRA Coags holds a niche position in the medical category, but its 1.27-star rating across 578 total ratings indicates severe user dissatisfaction following the recent subscription transition. The lack of competitive feature parity with mega-apps like Vargo Anesthesia leaves the app vulnerable to churn.

Rank progression

12 active rankings tracked — 30-day window

The rivals identified

Nemeses(1)

Vargo Anesthesia Mega App icon

Vargo Anesthesia Inc

4.6(1.6M)

Dominates the anesthesia niche with a comprehensive, high-frequency update cycle that dwarfs specialized tools.

Differentiators

  • Aggressive release cadence of nine updates in six months ensures constant feature evolution and stability.
  • Consolidates multiple anesthesia tools into one mega-app, creating a high barrier to entry for single-purpose apps.

Contenders(1)

Anesthesia Central icon
Anesthesia Centralmoat: medium

Unbound Medicine, Inc.

4.7(103)

Directly targets the same clinical audience with specialized anesthesia-focused reference content and decision support.

Differentiators

  • Integrates comprehensive drug databases and clinical calculators directly into the anesthesia reference workflow.
  • Leverages a professional-grade content platform that provides deeper clinical evidence than simple guideline-based apps.

Same space(4)

Doximity icon
Doximitymoat: high

Doximity

4.8(191.5K)

Captures the professional networking and clinical communication space, creating a high-frequency habit loop for physicians.

Differentiators

  • Combines professional networking, secure clinical communication, and medical news into a single, high-retention ecosystem.
  • Leverages a massive verified physician user base to drive engagement through professional utility rather than just reference.
UpToDate icon
UpToDatemoat: high

UpToDate, Inc.

4.3(11.3K)

The industry standard for clinical evidence, often serving as the primary source of truth for the guidelines ASRA Coags references.

Differentiators

  • Provides exhaustive, evidence-based clinical summaries that act as the definitive source for complex medical decision-making.
  • Maintains a massive institutional subscription base that effectively locks out smaller, niche-specific reference applications.
Calculate by QxMD icon
Calculate by QxMDmoat: medium

WebMD

4.5(13.2K)

A broad-spectrum clinical tool that competes for the same limited screen time during high-pressure clinical procedures.

Differentiators

  • Provides seamless integration with institutional electronic health records to streamline clinical documentation workflows.
  • Maintains a vast, cross-specialty library that captures users who prefer one-stop-shop medical utility apps.
MDCalc Medical Calculator icon

MD Aware, LLC

4.9(51.2K)

Provides essential clinical decision support tools that overlap with the procedural requirements of ASRA Coags users.

Differentiators

  • Offers a massive library of peer-reviewed calculators that serve as a daily utility for all medical specialties.
  • Utilizes a highly optimized, fast-loading interface that prioritizes quick clinical calculations over long-form guideline reading.

New entrants(1)

Pedi STAT icon
Pedi STATmoat: low

James M Kempema MD PA

4.5(64)

Represents a specialized, high-utility niche tool that demonstrates how focused procedural apps can gain traction.

Differentiators

  • Focuses exclusively on rapid, weight-based dosing for pediatric emergencies, solving a specific high-stress clinical pain point.
  • Prioritizes a simplified, zero-friction interface that allows clinicians to retrieve critical data in under five seconds.

Compare ASRA Coags against every rival

All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.

Go deeper

The outtake for ASRA Coags

Strengths to defend, gaps to attack

Core Strengths

  • Society-sanctioned clinical standards function as a primary distribution moat for professional practitioners.
  • Procedure-based search reduces clinical decision-making time, driving daily utility.

Critical Frictions

  • Subscription transition revoked lifetime access for legacy users, triggering a 1.27-star rating floor.
  • Technical instability and crashes reported following the latest update.

Growth Levers

  • Integration of wearable-based clinical alerts could provide a high-utility differentiator.
  • B2B partnerships with hospital systems could bypass individual subscription friction.

Market Threats

  • Vargo Anesthesia's nine-update-per-six-month cadence leaves ASRA Coags vulnerable to feature obsolescence.
  • Consolidated medical reference apps are siphoning screen time from single-purpose tools.

What are the next best moves?

highPivot

Grandfather legacy users into the current subscription tier because the lack of access for prior purchasers is the #1 sentiment driver → restore brand trust

Sentiment analysis identifies forced subscription as the primary cause of the 1.27-star rating.

Trade-off: Pause the annual subscription revenue growth target for Q1 — legacy retention is a prerequisite for long-term brand health.

highMaintain

Audit and stabilize the login flow because technical instability is reported as a circular failure → reduce churn

Users report the application has become unstable and prone to crashing post-update.

Trade-off: Delay the 2026 interventional pain guideline UI refresh — stability is the current baseline requirement.

A counter-intuitive read

The app's primary risk is not the subscription price, but the infrequent update cycle which makes it appear abandoned compared to the high-cadence mega-apps that dominate the anesthesia category.

Feature Gaps vs Competitors

  • Integrated clinical calculators (available in Anesthesia Central but absent here)
  • Institutional EHR integration (available in Calculate by QxMD but absent here)

Key Takeaways

ASRA Coags retains high clinical value, but the aggressive subscription pivot has alienated its core professional base, so the PM must prioritize grandfathering legacy users to halt the rating collapse.

Where Is It Heading?

Declining

The medical reference market is consolidating around high-frequency, multi-tool apps that prioritize stability and integration. ASRA Coags is currently exposed due to its infrequent update cycle and the reputational damage caused by the subscription transition, which will likely lead to further user churn unless the legacy access issue is resolved.

The transition to a subscription model has triggered a severe backlash from the professional medical user base, which is driving users to abandon the app.

Technical instability and application crashes reported following the transition to the new build are eroding the daily active habit.

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by ASRA Coags, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

What's new

The app's transition to a mandatory subscription model without legacy support has caused a severe decline in user sentiment and brand trust.

shifted

Subscription Model Implementation

declined

Rating and Sentiment Collapse

improved

Feature Repositioning

added

New Weaknesses and Threats

Cite this report

Marlvel.ai. “ASRA Coags Intelligence Report.” Updated May 22, 2026. https://marlvel.ai/apps/asra-coags

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0